Candace Vielma
Clinical Nurse Specialist, Gerontology Kyle, TX Clinical Nurse Specialist
NPI 1992266241 CMS profile 10951515
135 Bunton Creek Rd, Kyle, TX 78640
General payments
$1,272
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Candace Vielma of Kyle, TX is reported in the CMS Open Payments database as having received $1,272 across 14 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 78th percentile of Clinical Nurse Specialist, Gerontology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $462 | 6 | |
| 2024 | General | $190 | 2 | |
| 2023 | General | $589 | 4 | |
| 2022 | General | $14 | 1 | |
| 2021 | General | $17 | 1 |
Beside peers
- Candace Vielma
- Clinical Nurse Specialist, Gerontology median
- Middle half of Clinical Nurse Specialist, Gerontology
- National median
In program year 2025, general payments to Candace Vielma were reported at $462. Among 115 Clinical Nurse Specialist, Gerontology profiles paid that year, the median was $161 and the middle half received between $80 and $556.
Show as a table
| Year | Candace Vielma | Clinical Nurse Specialist, Gerontology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $17 | $146 | $38–$369 | $132 |
| 2022 | $14 | $127 | $48–$336 | $149 |
| 2023 | $589 | $174 | $43–$492 | $160 |
| 2024 | $190 | $209 | $72–$472 | $164 |
| 2025 | $462 | $161 | $80–$556 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 4 billing codesPaid by Medicare
$1,561
Medicare patients
16
Services billed
32
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
14 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Nurse Specialist, Gerontology in Texas
Andrew Barger
Clinical Nurse Specialist, Gerontology · Austin, TX
Martha Menefee
Clinical Nurse Specialist, Gerontology · Round Rock, TX
Benjamin Oheim
Clinical Nurse Specialist, Gerontology · Austin, TX
Matthew Rich
Clinical Nurse Specialist, Gerontology · Tyler, TX
Abigail Laney
Clinical Nurse Specialist, Gerontology · Richmond, TX
Kelly Coleman
Clinical Nurse Specialist, Gerontology · Austin, TX
Related records
Clinical Nurse Specialist, Gerontology in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Nurse Specialist, Gerontology
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.